NCT05936346View on ClinicalTrials.gov

Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Aging
Interventions
DIETARY_SUPPLEMENT

Salvia haenkei 175mg

The product appears as a soft gel containing the dry extract of Salvia haenkei

DIETARY_SUPPLEMENT

Salvia haenkei 350mg

The product appears as a soft gel containing the dry extract of Salvia haenkei

Trial Locations (1)

Unknown

RECRUITING

Ospedale Regionale di Lugano, Lugano

All Listed Sponsors
lead

IBSA Farmaceutici Italia Srl

INDUSTRY